In the EU indicated population (ApoE 4 non-carriers or heterozygotes) (n=757), the most common adverse reactions were infusion-related reaction (26%), ARIA-H (13%), headache (11%) and ARIA-E (9%).

Eisai (ESAIY) and Biogen (BIIB) announced that the anti-amyloid beta monoclonal antibody Leqembi has been launched in Austria on August 25 and ...

The trade deal between the United States and the European Union, which was announced by both sides with pride, may have ...

BioArctic AB's (publ) (NASDAQ Stockholm: BIOA B) partner Eisai announced today that the launch of Leqembi in the EU started in Austria on August 25, 2025, and will be launched in Germany on September ...

The vision is that Austrian drivers on holiday anywhere in Europe will simply present their ISO-standard mDL to local ...

Austria pushes EU to keep door open for Russian gas after war in Ukraine Vienna resists Brussels-proposed ban on fossil fuels, appealing for flexibility in case of future peace deal.

On the other hand, both Austria and the Netherlands approved Croatia's candidacy, a country that entered the European Union six years after Romania. Croatia will join Schengen as of January 2023.

Austria's green projects developer Enery Elements, with the Three Seas Initiative investment fund behind it, and Czech Rezolv ...

The question of Austrian participation in a peacekeeping mission in Ukraine is becoming the focus of Austria's military ...